Merck & Co’s experimental antiviral pill molnupiravir will be rolled out in the Philippines by November through hospitals and compassionate permits according to Filipino company MedEthix. MedEthix co-founder Monaliza Salian said in a press briefing that their supplier will cover 300,000 COVID-19-positive patients. RELATED STORY: Merck applies for US authorization for first COVID-19 pill “A …

The post COVID-19 antiviral drug to be rolled out in PH in November appeared first on The Filipino Times.